Referencias:

• Thijssen, R., Slinger, E., Weller, K., Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors (2015) Haematologica, 100 (8), pp. e302-e306
• Bojarczuk, K., Sasi, B.K., Gobessi, S., BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199 (2016) Blood, 127 (25), pp. 3192-3201
• Oppermann, S., Ylanko, J., Shi, Y., High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells (2016) Blood, 128 (7), pp. 934-947
• Palma, M., Gentilcore, G., Heimersson, K., T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers (2017) Haematologica, 102 (3), pp. 562-572
• Ghia, P., Strola, G., Granziero, L., Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22 (2002) Eur J Immunol, 32 (5), pp. 1403-1413
• Pizzolo, G., Chilosi, M., Ambrosetti, A., Semenzato, G., Fiore-Donati, L., Perona, G., Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia (1983) Blood, 62 (6), pp. 1289-1296
• Sharman, J., Hawkins, M., Kolibaba, K., An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia (2015) Blood, 125 (15), pp. 2336-2343
• Colado, A., Almejun, M.B., Podaza, E., The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated antitumor activity of rituximab in chronic lymphocytic leukemia patients (2017) Cancer Immunol Immunother, 66 (4), pp. 461-473
• Anderson, M.A., Tam, C., Lew, T.E., Clinico-pathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax (2017) Blood, 129 (25), pp. 3362-3370
• Sharman, J., Di Paolo, J., Targeting B-cell receptor signaling kinases in chronic lymphocytic leukemia: The promise of entospletinib (2016) Ther Adv Hematol, 7 (3), pp. 157-170
• Montalvao, F., Garcia, Z., Celli, S., The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging (2013) J Clin Invest, 123 (12), pp. 5098-5103
• Uchida, J., Hamaguchi, Y., Oliver, J.A., The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptordependent mechanisms during anti-CD20 antibody immunotherapy (2004) J Exp Med, 199 (12), pp. 1659-1669
• Ravichandran, K.S., Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums (2010) J Exp Med, 207 (9), pp. 1807-1817
• Freise, K.J., Jones, A.K., Menon, R.M., Relationship between venetoclax exposure, rituximab coadministration, and progression-free survival in patients with relapsed or refractory chronic lymphocytic leukemia: Demonstration of synergy (2016) Hematol Oncol, 35 (4), pp. 679-684

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------